• OPEN AN ACCOUNT
A+| A| A-|
Indian Indices
Sensex
76,676.40 -886.50
( -1.14%)
Global Indices
Nasdaq
47,935.11 1,329.65
(2.85%)
Dow Jones
6,804.45 166.60
(2.51%)
Hang Seng
55,958.99 -349.43
(-0.62%)
Nikkei 225
10,596.41 247.62
(2.39%)
Forex
USD-INR
92.90 -0.03
(-0.03%)
EUR-INR
107.45 0.22
(0.21%)
GBP-INR
123.16 0.23
(0.18%)
JPY-INR
0.58 0.00
(-0.10%)

EQUITY - MARKET SCREENER

Natco Pharma Ltd
Industry :  Pharmaceuticals - Indian - Bulk Drugs & Formln
BSE Code
ISIN Demat
Book Value()
524816
INE987B01026
461.79599
NSE Symbol
P/E(TTM)
Mar.Cap( Cr.)
NATCOPHARM
13.27
19909.85
EPS(TTM)
Face Value()
Div & Yield %
83.75
2
0.54
 

As on: Apr 09, 2026 03:26 PM

Last Price() Net Change (%) Volume (Nos) P / E
1,127.00 15.40 46616 13.27
Stock Price Details
Open Price() 1,110.00
Best Buy () 1127.4
Best Sell () 1127.45
Buy Quantity (Nos) 1
Sell Quantity (Nos) 1
Today's High () 1,127.50
Today's Low () 1,097.40
52-Week High () 1124
152-Week Low () 742.8
CHART
  • |
  • |
  • |
  • |
Market Statistics
Div & Yield % 0.54
Eps 83.75
Book Value 461.79599
Market Cap (.Cr) 19,909.85
Face Value 2
Market Lot 1
AGM Date Sep
Book Closure Date Sep
ISIN No. INE987B01026


News
Stock Alert: Adani Ports, Natco Pharma, Gland Pharma, Allied Blenders, JSW Cement
Natco Pharma gains on Pomalidomide capsules launch in US
Thangamayil Jewellery Ltd leads gainers in 'A' group
Easy Trip Planners Ltd leads gainers in 'A' group
Volumes spurt at C.E. Info Systems Ltd counter
Volumes jump at Natco Pharma Ltd counter
Natco Pharma receives CDSCO approval for launch of Semaglutide in India
Natco Pharma receives USFDA EIR report for API unit in Chennai
Natco Pharma consolidated net profit rises 13.91% in the December 2025 quarter
Board of Natco Pharma recommends interim dividend
More
Corporate Details
Incoporation Year   : 1981
Chairman : V C Nannapaneni
Bussiness Group : Natco
Registered Office
Natco Pharma Ltd
Natco House,
Road No 2 Banjara Hills,
Hyderabad,
Telangana-500033
Cement House,
121 Maharshi Karve Road,
Mumbai,
Maharashtra-400020
Phone:91-040-23547532
Fax:91-040-23548243
Fax:91-22-66317458
E-Mail : investors@natcopharma.co.in
URL : http://www.natcopharma.co.in


Exchange Information
Bombay Stock Exchange National Stock Exchange Other Listed Exchanges
  • BSE 500
  • BSE HC
  • BSE SmallCap
  • CNX 500
  • CNX SMALLCA
  • BSE
  • Kolkata
  • Chennai
  • Ahmedabad
  • Delhi
  • Kochi